Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,365 | 107 | 89.5% |
| Education | $394.92 | 4 | 10.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $757.00 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $653.00 | 15 | $0 (2024) |
| Lilly USA, LLC | $466.48 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $464.74 | 9 | $0 (2024) |
| Dermavant Sciences, Inc. | $357.34 | 12 | $0 (2023) |
| ABBVIE INC. | $312.53 | 15 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $171.83 | 9 | $0 (2024) |
| PFIZER INC. | $90.94 | 5 | $0 (2024) |
| UCB, Inc. | $88.97 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $86.13 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $916.59 | 29 | E.R. Squibb & Sons, L.L.C. ($200.74) |
| 2023 | $1,701 | 42 | E.R. Squibb & Sons, L.L.C. ($479.12) |
| 2022 | $724.29 | 26 | Lilly USA, LLC ($243.58) |
| 2021 | $417.80 | 14 | Janssen Biotech, Inc. ($116.99) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.21 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.32 | General |
| 11/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Dermatology | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.87 | General |
| Category: Immunology | ||||||
| 08/14/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: Immunology | ||||||
| 08/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Dermatology | ||||||
| 06/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $72.92 | General |
| Category: Immunology | ||||||
| 05/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: DERMATOLOGY | ||||||
| 05/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Immunology | ||||||
| 05/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $172.00 | General |
| Category: Immunology | ||||||
| 04/09/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Immunology | ||||||
| 03/19/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Immunology | ||||||
| 03/05/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: IMMUNOLOGY | ||||||
| 02/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/28/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Immunology | ||||||
| 02/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $103.92 | General |
| Category: Immunology | ||||||
| 02/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: Immunology | ||||||
| 02/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: Dermatology | ||||||
| 02/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.53 | General |
| Category: Immunology | ||||||
| 02/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.39 | General |
| Category: Immunology | ||||||
| 02/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,591 | 4,782 | $585,120 | $169,444 |
| 2022 | 17 | 2,522 | 4,541 | $514,134 | $152,565 |
| 2021 | 12 | 1,564 | 2,375 | $277,964 | $90,548 |
| 2020 | 8 | 510 | 1,019 | $108,431 | $30,497 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 873 | 1,230 | $193,119 | $67,090 | 34.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 415 | 526 | $75,474 | $18,030 | 23.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 237 | 261 | $63,467 | $17,186 | 27.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 219 | 254 | $55,696 | $13,831 | 24.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 52 | 56 | $36,393 | $11,497 | 31.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 152 | 152 | $34,813 | $8,623 | 24.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 377 | 1,938 | $27,897 | $8,446 | 30.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 59 | 79 | $28,482 | $8,092 | 28.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 65 | 92 | $10,017 | $2,969 | 29.6% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 11 | 12 | $8,163 | $2,633 | 32.3% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $8,710 | $2,581 | 29.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 25 | 28 | $14,535 | $2,540 | 17.5% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 19 | 21 | $12,478 | $2,029 | 16.3% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 16 | 16 | $9,152 | $1,484 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 15 | $3,473 | $1,313 | 37.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 33 | $3,140 | $1,050 | 33.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 56 | $112.00 | $48.91 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 706 | 940 | $143,820 | $51,666 | 35.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 394 | 487 | $67,160 | $16,160 | 24.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 233 | 273 | $57,849 | $15,554 | 26.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 203 | 218 | $51,198 | $13,857 | 27.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 46 | 51 | $32,238 | $9,804 | 30.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 71 | 85 | $29,505 | $9,075 | 30.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 275 | 304 | $28,272 | $8,683 | 30.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 357 | 1,845 | $23,692 | $7,897 | 33.3% |
About Patrick Duffy, PA
Patrick Duffy, PA is a Physician Assistant healthcare provider based in Rehoboth Beach, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780748368.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patrick Duffy, PA has received a total of $3,759 in payments from pharmaceutical and medical device companies, with $916.59 received in 2024. These payments were reported across 111 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,365).
As a Medicare-enrolled provider, Duffy has provided services to 7,187 Medicare beneficiaries, totaling 12,717 services with total Medicare billing of $443,053. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Rehoboth Beach, DE
- Active Since 12/20/2006
- Last Updated 10/26/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1780748368
Products in Payments
- Sotyktu (Drug) $662.01
- TREMFYA (Drug) $620.63
- VTAMA (Drug) $357.34
- LIBTAYO (Biological) $258.69
- TALTZ (Drug) $231.03
- DUPIXENT (Biological) $223.13
- SKYRIZI (Biological) $194.08
- EUCRISA (Drug) $90.94
- Cimzia (Drug) $88.97
- OPZELURA (Drug) $83.80
- BLU-U (Medical Supply) $82.05
- Otezla (Drug) $59.78
- RINVOQ (Biological) $59.33
- HUMIRA (Biological) $59.12
- COSENTYX (Drug) $53.32
- Erivedge (Biological) $46.21
- OLUMIANT (Drug) $43.24
- Odomzo (Drug) $36.96
- REMICADE (Biological) $32.37
- Haegarda (Biological) $31.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Rehoboth Beach
Mike Bevers
Physician Assistant — Payments: $5,103
Alexander Chase, Pa-C, PA-C
Physician Assistant — Payments: $644.71
Robert Barwick, Pa, PA
Physician Assistant — Payments: $569.97
Noor Al-Rashid
Physician Assistant — Payments: $150.04
Ms. Tricia Ecker, Pa-C, PA-C
Physician Assistant — Payments: $18.04
Andrew Fitzkee, P.a, P.A
Physician Assistant